Skip to content

Current status and influencing factors of patients in endocrine therapy for breast cancer

Current status and influencing factors of patients in endocrine therapy for breast cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089127
Enrollment
Unknown
Registered
2024-09-02
Start date
2024-04-22
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms

Interventions

Observation group:none

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Women aged over 18 years; (2) Patients with stage I-III primary breast cancer confirmed by pathology; (3) Estrogen and/or progesterone receptor positive, is receiving endocrine therapy; (4) Patients participated in this study voluntarily.

Exclusion criteria

Exclusion criteria: (1) Combined with other vital organ dysfunction; (2) Combined with other cancers and major cardiovascular and cerebrovascular diseases; (3) Unable to communicate normally.

Design outcomes

Primary

MeasureTime frame
Patient activeness;

Secondary

MeasureTime frame
Breast Cancer Survivors Self-efficacy Scale, BCSE;Memory Symptom Assessment Scale, MSAS;Social Support Revalued Scale,SSRS;

Countries

China

Contacts

Public ContactShi Tieying

The First Affiliated Hospital of Dalian Medical University

sty11177@163.com+86 180 9887 1912

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026